Therapeutic Evaluation of Habb-E-Suranjan In Hyperuricemia
Published in December 2016 Issue 6 (Vol. 6, Issue 6, 2016)

Abstract
Authors (3)
Ehsan Rauf
Research Associate (Unani), Ce...Research Associate (Unani), Central Research Insti...Research Associate (Unani), Central Research Institute of Unani Medici...Research Associate (Unani), Central Research Institute of Unani Medicine, Lucknow, UP, India.
View all publications →M.Mohsin
Research Associate (Unani), Ce...Research Associate (Unani), Central Research Insti...Research Associate (Unani), Central Research Institute of Unani Medici...Research Associate (Unani), Central Research Institute of Unani Medicine, Lucknow, UP, India.
View all publications →Tabassum Latafat
Research Associate (Unani), Ce...Research Associate (Unani), Central Research Insti...Research Associate (Unani), Central Research Institute of Unani Medici...Research Associate (Unani), Central Research Institute of Unani Medicine, Lucknow, UP, India.
View all publications →Download Article
Best for printing and citation
Download Article
Best for printing and citation
Article Information
Published in:
December 2016 Issue 6 (Vol. 6, Issue 6, 2016)AJPTR66043
AJPTR-01-002752
2016-12-01
Article Impact
How to Cite
Rauf & M.Mohsin & Latafat (2016). Therapeutic Evaluation of Habb-E-Suranjan In Hyperuricemia. American Journal of PharmTech Research, 6(6), xx-xx. https://ajptr.com/articles/AJPTR66043
Article Actions
More from this Issue
Pulsatile Drug Delivery System: A Review
Lichen Secondary Metabolites and Its Biological Activity
A Review on Time Dependent Pharmacokinetics
More by These Authors
Synthesis, Characterization and Cytotoxic Activity of New Palladium Complexes with 3-Thiolanespiro-5’-Hydantoin and 4-Thio-1h-Tetrahydropyranespiro-5’-Hydantoin
2014 • Vol. 4, Issue 4
Read more →